Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4F. Hoffmann-La Roche

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SAQUINAVIR MESYLATE

Brand Name : INVIRASE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 1995-12-06

Application Number : 20628

Regulatory Info : DISCN

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SAQUINAVIR MESYLATE

Brand Name : INVIRASE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 2004-12-17

Application Number : 21785

Regulatory Info : DISCN

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

sakvinavirmesilat

Brand Name : Invirase

Dosage Form : FILM COATED PILL

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

sakvinavirmesilat

Brand Name : Invirase

Dosage Form : HARD CAPSULES

Dosage Strength : 200 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank